{
  "resourceType": "ValueSet",
  "id": "2.16.840.1.113883.3.3616.200.110.102.5092",
  "meta": {
    "versionId": "5",
    "lastUpdated": "2022-07-15T01:02:56.000-04:00"
  },
  "url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3616.200.110.102.5092",
  "version": "20220715",
  "name": "Percent Neutralization by SARS Coronavirus 2 Spike Protein RBD Neutralizing Antibody, Ser/Plas",
  "status": "active",
  "date": "2022-07-15T01:02:56-04:00",
  "publisher": "Clinical Architecture",
  "compose": {
    "include": [
      {
        "system": "http://loinc.org",
        "version": "2.72",
        "concept": [
          {
            "code": "98733-9",
            "display": "Percent neutralization by SARS coronavirus 2 spike protein RBD neutralizing antibody in Serum or Plasma by Immunoassay"
          }
        ]
      }
    ]
  },
  "expansion": {
    "identifier": "urn:uuid:d6576514-2db9-400f-a216-ecedaac11767",
    "timestamp": "2022-09-28T05:48:37-04:00",
    "total": 1,
    "offset": 0,
    "parameter": [
      {
        "name": "count",
        "valueInteger": 1000
      },
      {
        "name": "offset",
        "valueInteger": 0
      }
    ],
    "contains": [
      {
        "system": "http://loinc.org",
        "version": "2.72",
        "code": "98733-9",
        "display": "Percent neutralization by SARS coronavirus 2 spike protein RBD neutralizing antibody in Serum or Plasma by Immunoassay"
      }
    ]
  }
}